Chenguang Biotech Group (300138) — Net Asset Momentum
Chenguang Biotech Group (300138) recorded a net asset momentum of -10.7% as of December 2024, with net assets of CN¥3.15 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check tangible net worth ratio of Chenguang Biotech Group to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Chenguang Biotech Group Net Asset Momentum (2007–2024)
This chart tracks Chenguang Biotech Group's year-over-year net asset growth across 18 annual reporting periods from 2007 to 2024. The most recent momentum reading is -10.7%, with net assets of CN¥3.15 Billion CNY as of December 2024. Read 300138 current and long-term liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Chenguang Biotech Group (2007–2024)
The table below shows the complete annual net asset history for Chenguang Biotech Group from 2007 to 2024, covering 18 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Chenguang Biotech Group stock valuation.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥3.15 Billion | CN¥9.02 Billion | CN¥5.87 Billion | ▼ -10.7% |
| 2023 | CN¥3.53 Billion | CN¥8.54 Billion | CN¥5.01 Billion | ▲ +9.9% |
| 2022 | CN¥3.21 Billion | CN¥6.92 Billion | CN¥3.71 Billion | ▲ +15.5% |
| 2021 | CN¥2.78 Billion | CN¥5.96 Billion | CN¥3.17 Billion | ▲ +35.1% |
| 2020 | CN¥2.06 Billion | CN¥4.65 Billion | CN¥2.59 Billion | ▲ +18.3% |
| 2019 | CN¥1.74 Billion | CN¥4.51 Billion | CN¥2.77 Billion | ▲ +0.1% |
| 2018 | CN¥1.74 Billion | CN¥3.36 Billion | CN¥1.62 Billion | ▲ +7.2% |
| 2017 | CN¥1.62 Billion | CN¥2.87 Billion | CN¥1.25 Billion | ▲ +6.5% |
| 2016 | CN¥1.52 Billion | CN¥2.49 Billion | CN¥967.46 Million | ▲ +6.9% |
| 2015 | CN¥1.43 Billion | CN¥1.99 Billion | CN¥564.12 Million | ▲ +41.5% |
| 2014 | CN¥1.01 Billion | CN¥1.51 Billion | CN¥499.69 Million | ▲ +1.8% |
| 2013 | CN¥990.39 Million | CN¥1.63 Billion | CN¥641.26 Million | ▼ -0.7% |
| 2012 | CN¥997.86 Million | CN¥1.45 Billion | CN¥447.73 Million | ▲ +3.0% |
| 2011 | CN¥968.71 Million | CN¥1.12 Billion | CN¥147.16 Million | ▲ +3.8% |
| 2010 | CN¥933.05 Million | CN¥1.15 Billion | CN¥215.92 Million | ▲ +342.9% |
| 2009 | CN¥210.67 Million | CN¥402.85 Million | CN¥192.17 Million | ▲ +42.4% |
| 2008 | CN¥147.93 Million | CN¥385.24 Million | CN¥237.31 Million | ▲ +45.5% |
| 2007 | CN¥101.70 Million | CN¥187.20 Million | CN¥85.49 Million | — |